Opportunities missed
D + C, Development and Cooperation
; 48(7/8):30-30, 2021.
Article
in English
| GIM | ID: covidwho-2156658
ABSTRACT
A new era for boosting immunization progress worldwide has begun with the introduction of the Immunization Agenda 2030 (IA2030). The COVID-19 pandemic, which severely disrupted regular immunization programs, marked a turning point in this transformation in many respects. Importantly, the article highlights the pressing problems that must be resolved in the new IA2030 age as vaccination hesitation, false information, unequal access, governmental inertia, and commercial interest protection. In addition to these difficulties, they argue in favor of giving lost chances for immunization priority. Any time a person who is eligible for vaccination contacts health care providers but does not receive either one or both of the vaccine doses for which they are qualified, this is referred to as a missed opportunity for immunization. Unquestionably, global immunization rates have stagnated below the goals of the Global Vaccine Action Plan. The worldwide suspension of routine immunization programs as a result of the COVID-19 epidemic has further hampered progress. Missed immunization chances are common but vary within and among nations, sometimes reaching 89%. In order to meet the Global Vaccine Action Plan's unmet objectives and provide catch-up vaccines to reverse the pandemic's negative effects on immunization progress, it is now crucial to address missed chances for vaccination. Fulfilling IA2030's vision will require a thorough understanding of the burden of missed opportunities for vaccination and its multidimensional determinants at national and sub-national levels, the implementation of context-appropriate corrective measures, and periodic progress monitoring, in line with its fourth strategic priority.
Search on Google
Collection:
Databases of international organizations
Database:
GIM
Language:
English
Journal:
D / C, Development and Cooperation
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS